Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable
Wolfgang G Philipp-Dormston,1,2 Koenraad De Boulle,3,4 David B Eccleston,5 Rachna Murthy,6 Karim Sayed,7– 9 Philippe Snozzi,10,11 Fernando Urdiales-Galvez12 1Hautzentrum Köln, Cologne, Germany; 2Faculty of Health, University Witten/Herdecke, Witten, Germany; 3Aalst Dermatology Clinic, Aalst, Belgium...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/prevention-and-management-of-complications-with-a-hyaluronic-acidcalci-peer-reviewed-fulltext-article-CCID |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850190359540269056 |
|---|---|
| author | Philipp-Dormston WG De Boulle K Eccleston DB Murthy R Sayed K Snozzi P Urdiales-Galvez F |
| author_facet | Philipp-Dormston WG De Boulle K Eccleston DB Murthy R Sayed K Snozzi P Urdiales-Galvez F |
| author_sort | Philipp-Dormston WG |
| collection | DOAJ |
| description | Wolfgang G Philipp-Dormston,1,2 Koenraad De Boulle,3,4 David B Eccleston,5 Rachna Murthy,6 Karim Sayed,7– 9 Philippe Snozzi,10,11 Fernando Urdiales-Galvez12 1Hautzentrum Köln, Cologne, Germany; 2Faculty of Health, University Witten/Herdecke, Witten, Germany; 3Aalst Dermatology Clinic, Aalst, Belgium; 4University College London, London, UK; 5MediZen, Birmingham, UK; 6FaceRestoration, Ltd, London, UK; 7Nomi Oslo Clinic, Oslo, Norway; 8Ouronyx Clinic, London, UK; 9University of South-Eastern Norway, Drammen, Norway; 10Smoothline, Zurich, Switzerland; 11University of Amsterdam, Amsterdam, Netherlands; 12Instituto Médico Miramar, Málaga, SpainCorrespondence: Wolfgang G Philipp-Dormston, Hautzentrum Köln, Schillingsrotter Str. 39-41, Köln, 50996, Germany, Tel +49 221 390 00 200, Fax +49 221 390 00 201, Email wdormston@outlook.comBackground: A ready-to-use hyaluronic acid–calcium hydroxyapatite (HA-CaHA) hybrid injectable has a dual mode of action for soft-tissue augmentation. Although previous studies have reported a favorable safety profile for HA-CaHA, there is a need for guidelines and recommendations based on real-world clinical experience for the management of complications associated with HA-CaHA.Purpose: This publication provides guidelines and recommendations for the prevention and management of HA-CaHA–related complications. A case study example, treatment algorithms, and injection techniques are included to illustrate the management of complications.Materials and Methods: On January 25, 2023, 13 European physicians were invited to an advisory board meeting to discuss strategies for optimizing patient care, minimizing adverse events (AEs), and identifying data gaps for the prevention and management of complications with HA-CaHA.Results: The management of a subset of AEs, including skin discoloration and edema, was discussed. Small group workshops also shared management algorithms for late noninflammatory adverse reactions, late inflammatory adverse reactions, localized vascular complications, and retinal vascular complications. Best practices for optimal injection techniques were discussed, and injection-technique protocols were developed for treatment sites. Treatment strategies for HA-CaHA–related complications are considered similar to treatment of those resulting from single-agent fillers, and knowledge of anatomy, aseptic technique, correct injection techniques, and appropriate posttreatment care is emphasized.Conclusion: These recommendations on the management of HA-CaHA–related complications may serve as a reference for the broad range of clinicians using HA-CaHA hybrid injectable for different indications and can help optimize patient outcomes and safety.Keywords: hyaluronic acid, calcium hydroxyapatite, prevention, complications |
| format | Article |
| id | doaj-art-e532fc54a45d4bff8678c44a9f1c08db |
| institution | OA Journals |
| issn | 1178-7015 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical, Cosmetic and Investigational Dermatology |
| spelling | doaj-art-e532fc54a45d4bff8678c44a9f1c08db2025-08-20T02:15:19ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152025-02-01Volume 18431441100441Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid InjectablePhilipp-Dormston WGDe Boulle KEccleston DBMurthy RSayed KSnozzi PUrdiales-Galvez FWolfgang G Philipp-Dormston,1,2 Koenraad De Boulle,3,4 David B Eccleston,5 Rachna Murthy,6 Karim Sayed,7– 9 Philippe Snozzi,10,11 Fernando Urdiales-Galvez12 1Hautzentrum Köln, Cologne, Germany; 2Faculty of Health, University Witten/Herdecke, Witten, Germany; 3Aalst Dermatology Clinic, Aalst, Belgium; 4University College London, London, UK; 5MediZen, Birmingham, UK; 6FaceRestoration, Ltd, London, UK; 7Nomi Oslo Clinic, Oslo, Norway; 8Ouronyx Clinic, London, UK; 9University of South-Eastern Norway, Drammen, Norway; 10Smoothline, Zurich, Switzerland; 11University of Amsterdam, Amsterdam, Netherlands; 12Instituto Médico Miramar, Málaga, SpainCorrespondence: Wolfgang G Philipp-Dormston, Hautzentrum Köln, Schillingsrotter Str. 39-41, Köln, 50996, Germany, Tel +49 221 390 00 200, Fax +49 221 390 00 201, Email wdormston@outlook.comBackground: A ready-to-use hyaluronic acid–calcium hydroxyapatite (HA-CaHA) hybrid injectable has a dual mode of action for soft-tissue augmentation. Although previous studies have reported a favorable safety profile for HA-CaHA, there is a need for guidelines and recommendations based on real-world clinical experience for the management of complications associated with HA-CaHA.Purpose: This publication provides guidelines and recommendations for the prevention and management of HA-CaHA–related complications. A case study example, treatment algorithms, and injection techniques are included to illustrate the management of complications.Materials and Methods: On January 25, 2023, 13 European physicians were invited to an advisory board meeting to discuss strategies for optimizing patient care, minimizing adverse events (AEs), and identifying data gaps for the prevention and management of complications with HA-CaHA.Results: The management of a subset of AEs, including skin discoloration and edema, was discussed. Small group workshops also shared management algorithms for late noninflammatory adverse reactions, late inflammatory adverse reactions, localized vascular complications, and retinal vascular complications. Best practices for optimal injection techniques were discussed, and injection-technique protocols were developed for treatment sites. Treatment strategies for HA-CaHA–related complications are considered similar to treatment of those resulting from single-agent fillers, and knowledge of anatomy, aseptic technique, correct injection techniques, and appropriate posttreatment care is emphasized.Conclusion: These recommendations on the management of HA-CaHA–related complications may serve as a reference for the broad range of clinicians using HA-CaHA hybrid injectable for different indications and can help optimize patient outcomes and safety.Keywords: hyaluronic acid, calcium hydroxyapatite, prevention, complicationshttps://www.dovepress.com/prevention-and-management-of-complications-with-a-hyaluronic-acidcalci-peer-reviewed-fulltext-article-CCIDhyaluronic acidcalcium hydroxyapatitepreventioncomplications |
| spellingShingle | Philipp-Dormston WG De Boulle K Eccleston DB Murthy R Sayed K Snozzi P Urdiales-Galvez F Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable Clinical, Cosmetic and Investigational Dermatology hyaluronic acid calcium hydroxyapatite prevention complications |
| title | Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable |
| title_full | Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable |
| title_fullStr | Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable |
| title_full_unstemmed | Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable |
| title_short | Prevention and Management of Complications With a Hyaluronic Acid–Calcium Hydroxyapatite Hybrid Injectable |
| title_sort | prevention and management of complications with a hyaluronic acid ndash calcium hydroxyapatite hybrid injectable |
| topic | hyaluronic acid calcium hydroxyapatite prevention complications |
| url | https://www.dovepress.com/prevention-and-management-of-complications-with-a-hyaluronic-acidcalci-peer-reviewed-fulltext-article-CCID |
| work_keys_str_mv | AT philippdormstonwg preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable AT deboullek preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable AT ecclestondb preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable AT murthyr preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable AT sayedk preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable AT snozzip preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable AT urdialesgalvezf preventionandmanagementofcomplicationswithahyaluronicacidndashcalciumhydroxyapatitehybridinjectable |